IBDEI1BF ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23605,1,3,0)
 ;;=3^716.17
 ;;^UTILITY(U,$J,358.3,23605,1,5,0)
 ;;=5^Arthritis, Traumatic arthropathy- ankle/foot/toe
 ;;^UTILITY(U,$J,358.3,23605,2)
 ;;=^272186
 ;;^UTILITY(U,$J,358.3,23606,0)
 ;;=715.90^^141^1458^30
 ;;^UTILITY(U,$J,358.3,23606,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23606,1,3,0)
 ;;=3^715.90
 ;;^UTILITY(U,$J,358.3,23606,1,5,0)
 ;;=5^Arthritis, Osteoarthrosis- unspecified site-
 ;;^UTILITY(U,$J,358.3,23606,2)
 ;;=^272161
 ;;^UTILITY(U,$J,358.3,23607,0)
 ;;=V45.4^^141^1458^34
 ;;^UTILITY(U,$J,358.3,23607,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23607,1,3,0)
 ;;=3^V45.4
 ;;^UTILITY(U,$J,358.3,23607,1,5,0)
 ;;=5^Arthrodesis Status
 ;;^UTILITY(U,$J,358.3,23607,2)
 ;;=^97131
 ;;^UTILITY(U,$J,358.3,23608,0)
 ;;=440.20^^141^1458^26
 ;;^UTILITY(U,$J,358.3,23608,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23608,1,3,0)
 ;;=3^440.20
 ;;^UTILITY(U,$J,358.3,23608,1,5,0)
 ;;=5^Arterisclerosis obliterans- extermity
 ;;^UTILITY(U,$J,358.3,23608,2)
 ;;=^294064
 ;;^UTILITY(U,$J,358.3,23609,0)
 ;;=701.8^^141^1458^35
 ;;^UTILITY(U,$J,358.3,23609,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23609,1,3,0)
 ;;=3^701.8
 ;;^UTILITY(U,$J,358.3,23609,1,5,0)
 ;;=5^Atrophy, fat pad
 ;;^UTILITY(U,$J,358.3,23609,2)
 ;;=^88076
 ;;^UTILITY(U,$J,358.3,23610,0)
 ;;=V54.89^^141^1458^15
 ;;^UTILITY(U,$J,358.3,23610,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23610,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,23610,1,5,0)
 ;;=5^Aftercare,Post-op, Ortho
 ;;^UTILITY(U,$J,358.3,23610,2)
 ;;=Aftercare post Surg^328685
 ;;^UTILITY(U,$J,358.3,23611,0)
 ;;=V58.49^^141^1458^16
 ;;^UTILITY(U,$J,358.3,23611,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23611,1,3,0)
 ;;=3^V58.49
 ;;^UTILITY(U,$J,358.3,23611,1,5,0)
 ;;=5^Aftercare,following Surgery
 ;;^UTILITY(U,$J,358.3,23611,2)
 ;;=^295530
 ;;^UTILITY(U,$J,358.3,23612,0)
 ;;=274.00^^141^1458^27
 ;;^UTILITY(U,$J,358.3,23612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23612,1,3,0)
 ;;=3^274.00
 ;;^UTILITY(U,$J,358.3,23612,1,5,0)
 ;;=5^Arthritis, Gouty NOS
 ;;^UTILITY(U,$J,358.3,23612,2)
 ;;=^338313
 ;;^UTILITY(U,$J,358.3,23613,0)
 ;;=736.76^^141^1458^11
 ;;^UTILITY(U,$J,358.3,23613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23613,1,3,0)
 ;;=3^736.76
 ;;^UTILITY(U,$J,358.3,23613,1,5,0)
 ;;=5^Adductovarus (metatarsus) acquired
 ;;^UTILITY(U,$J,358.3,23613,2)
 ;;=^272748
 ;;^UTILITY(U,$J,358.3,23614,0)
 ;;=274.01^^141^1458^28
 ;;^UTILITY(U,$J,358.3,23614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23614,1,3,0)
 ;;=3^274.01
 ;;^UTILITY(U,$J,358.3,23614,1,5,0)
 ;;=5^Arthritis, Gouty, Acute
 ;;^UTILITY(U,$J,358.3,23614,2)
 ;;=^338226
 ;;^UTILITY(U,$J,358.3,23615,0)
 ;;=V54.89^^141^1458^14
 ;;^UTILITY(U,$J,358.3,23615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23615,1,3,0)
 ;;=3^V54.89
 ;;^UTILITY(U,$J,358.3,23615,1,5,0)
 ;;=5^Aftercare NEC
 ;;^UTILITY(U,$J,358.3,23615,2)
 ;;=^328685
 ;;^UTILITY(U,$J,358.3,23616,0)
 ;;=V67.09^^141^1458^13
 ;;^UTILITY(U,$J,358.3,23616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23616,1,3,0)
 ;;=3^V67.09
 ;;^UTILITY(U,$J,358.3,23616,1,5,0)
 ;;=5^After Surgery F/U Visit
 ;;^UTILITY(U,$J,358.3,23616,2)
 ;;=^322080
 ;;^UTILITY(U,$J,358.3,23617,0)
 ;;=216.7^^141^1459^2
 ;;^UTILITY(U,$J,358.3,23617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23617,1,3,0)
 ;;=3^216.7
 ;;^UTILITY(U,$J,358.3,23617,1,5,0)
 ;;=5^Benign neoplasm skin- lower limb, including hip
 ;;^UTILITY(U,$J,358.3,23617,2)
 ;;=^267636
 ;;^UTILITY(U,$J,358.3,23618,0)
 ;;=917.2^^141^1459^3
 ;;^UTILITY(U,$J,358.3,23618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,23618,1,3,0)
 ;;=3^917.2
